GGrantIndex
← Leaderboards

Cynthia K Sites

University Of Vermont &St Agric College

$1,338,168
Attributed
$1,338,168
Total exposure
8
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $203.1K · FY200508
$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08

Funding mix

By agency

NIH$1,338,168 · 8

By mechanism

K24$664,420 · 1
R29$427,469 · 1
M01$246,279 · 6

Top collaborators

No co-investigators on record.

Most similar at University Of Vermont &St Agric College

Same institution · by research overlap

Others in their field

Top investigators on “Female

Research focus

FemalePostmenopauseBody CompositionObesityClinical ResearchHuman Therapy EvaluationWomen'S HealthHormone TherapyHuman SubjectInsulin Sensitivity /ResistanceAdipose TissueGlucose Clamp TechniqueComputed Axial TomographyOutcomes ResearchPhoton AbsorptiometryCardiovascular DisorderLongitudinal Human StudyDisease /Disorder Proneness /RiskMenopausePlacebosPhytoestrogensGlucose MetabolismClinical TrialsDietary Supplementation

Grant awards (21)

Soy phytoestrogen supplementation and menopause$132,884
K24 · FY2008 · RR · contact PI
Soy phytoestrogen supplementation and menopause$132,884
K24 · FY2007 · RR · contact PI
SOY AND METABOLISM IN MENOPAUSE$39,581
M01 · FY2007 · RR · contact PI
Soy phytoestrogen supplementation and menopause$132,884
K24 · FY2006 · RR · contact PI
SOY PHYTOESTROGENS AND METABOLIC CARDIOVASCULAR RISK$42,025
M01 · FY2006 · RR · contact PI
SOY AND METABOLISM IN MENOPAUSE$2,350
M01 · FY2006 · RR · contact PI
Soy phytoestrogen supplementation and menopause$132,884
K24 · FY2005 · RR
SOY PHYTOESTROGENS AND METABOLIC CARDIOVASCULAR RISK$70,230
M01 · FY2005 · RR
Soy phytoestrogen supplementation and menopause$132,884
K24 · FY2004 · RR
Hormone Replacement Therapy and Metabolic Cardiovascular Risk$75,147
M01 · FY2004 · RR
Soy Phytoestrogens and Metabolic Cardiovascular Risk$16,946
M01 · FY2004 · RR
HORMONE REPLACEMENT AND METABOLIC CARDIOVASCULAR RISK$110,629
R29 · FY2003 · AG
HORMONE REPLACEMENT AND METABOLIC CARDIOVASCULAR RISK$108,093
R29 · FY2002 · AG
HORMONE REPLACEMENT THERAPY AND METABOLIC CARDIOVASCULAR RISK$0
M01 · FY2002 · RR
HORMONE REPLACEMENT, HEMODYNAMICS, BLOOD VOLUME$0
M01 · FY2002 · RR
HORMONE REPLACEMENT AND METABOLIC CARDIOVASCULAR RISK$105,629
R29 · FY2001 · AG
HORMONE REPLACEMENT AND METABOLIC CARDIOVASCULAR RISK$103,118
R29 · FY2000 · AG
HORMONE REPLACEMENT THERAPY AND METABOLIC CARDIOVASCULAR RISK$0
M01 · FY2000 · RR
HORMONE REPLACEMENT, HEMODYNAMICS, BLOOD VOLUME$0
M01 · FY2000 · RR
HORMONE REPLACEMENT, HEMODYNAMICS, BLOOD VOLUME$0
M01 · FY2000 · RR
HORMONE REPLACEMENT THERAPY AND METABOLIC CARDIOVASCULAR RISK$0
M01 · FY2000 · RR